Tatva Chintan Pharma Chem Ltd (TATVA) — Voting Results | 26 September 2026

26 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

All 10 resolutions passed at 30th AGM including director reappointments and borrowing limit increase.

💡 Investor Takeaway

Shareholders approved all key governance and financial proposals, confirming board continuity and capital flexibility.

At the 30th AGM held on 25 September 2026 via video conferencing, all 10 proposed resolutions were passed with requisite majority, including approval of audited standalone financial statements for FY2026, dividend declaration, director reappointments, increased borrowing limits, and ratification of cost auditor remuneration. Shareholders approved the reappointment of Mr. Chintan Shah as Managing Director for three years effective 1 February 2027 and Mr. Ajay Patel as Whole-time Director, alongside other governance matters.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TATVA ✨ Ask AI About This

About Tatva Chintan Pharma Chem Ltd (TATVA)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹4,120.16 CrP/E: 80.2ROE: 6.6%ROCE: 8.2%Div Yield: 0.11%

View full TATVA stock details →

📡 Get AI alerts when TATVA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TATVA — Free

💡 Ask AI about this filing

"What is the new borrowing limit amount?""How does the director remuneration compare to peers?""What was the exact dividend per share amount?"

Ask AI Free →

📊 More TATVA filings

🟡 Board Meeting — 25 September 2026Tatva Chintan Pharma Chem held its 30th AGM on 25 September 2026 via video conference, confirming qu...
Announcement — 23 September 2026Tatva Chintan Pharma Chem Ltd announced that its designated persons and immediate relatives must not...
🔴 Announcement — 17 September 2026Tatva Chintan Pharma Chem Ltd announced its schedule for upcoming analyst and investor meetings, inc...
🔴 Announcement — 8 September 2026Tatva Chintan Pharma Chem announced its schedule for upcoming analyst and investor meetings, includi...
🔴 Announcement — 8 September 2026Tatva Chintan Pharma Chem announced a credit rating upgrade from CRISIL BBB+/Stable to A-/Stable for...

See all TATVA filings →

🔥 Also filed on 26 September 2026

RPGLIFERPG Life Sciences LtdCorporate Action WHEELSWheels India LtdCorporate Action NURECANureca LtdInsider Trading 540786Sharika Enterprises LtdCorporate Action CHOLAFINCholamandalam Investment & Finance Company LtdCorporate Action 530217Swojas Foods LtdInsider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TATVA files new disclosures

Track TATVA filings, board meetings, and corporate actions. Free email alerts at 5 PM.